PowerPoint Presentation

[Virtual Presenter] The medical community has made significant strides in developing treatments for diabetic foot ulcers and chronic wounds. Recent case studies have demonstrated the effectiveness of LYTONIC Plus 500mg Capsules and LYTONIC Gel in promoting faster healing and reducing complications..

[Audio] Diabetic Foot Ulcers and intractable wounds are significant challenges in modern healthcare, often leading to severe complications, including infections, amputations, and reduced quality of life. Despite advancements in treatment modalities, achieving consistent and effective healing in such cases remains an unmet need. LYTONIC PLUS 500MG Capsules and LYTONIC Gel 40ML, innovative products formulated with advanced nanotechnology and herbal ingredients, offer a synergistic solution designed to address this critical gap in wound care..

[Audio] Patients with diabetic foot ulcers and non-healing wounds experienced remarkable progress in healing after incorporating LYTONIC into their treatment regimens. This demonstrates the exceptional therapeutic potential of LYTONIC in accelerating tissue regeneration, mitigating inflammation, and facilitating effective wound closure..

[Audio] The 62-year-old male patient from Albania presents with a diabetic foot ulcer with edema affecting his left little toe. The condition is characterized by localized infection, swelling, discoloration, and degree of gangrene and necrosis. His symptoms include severe swelling, pain, and ulceration. The patient's medical history reveals long-standing diabetes with poor glycemic control. Prior to treatment, the patient's condition had not shown any signs of improvement..

[Audio] The treatment protocol consists of administering LYTONIC Plus 500mg capsules twice daily and applying LYTONIC Gel 40ml twice daily. Furthermore, regular wound cleaning, antibiotics, and antifungal medication are employed as part of the comprehensive treatment plan. As a result, patients exhibit significant improvements in edema reduction, ulcer healing progress, pain alleviation, and skin condition..

[Audio] At this stage, we have observed a continued improvement in tissue viability, with further reduction in necrotic tissue and increased evidence of revascularization. We are also seeing a sustained decrease in inflammation and edema, which is indicative of effective control over localized inflammation..

[Audio] By the first week, noticeable alleviation of pain in the affected fingers was observed, contributing to better functionality and patient comfort. Enhanced overall circulation, likely due to the synergistic effects of LYTONIC Capsules and Gel in promoting vascular health, was also noted. Furthermore, stabilization of symptoms related to atherosclerosis was observed, reducing the risk of progression or new embolic events..

[Audio] The patient, a 67-year-old man from Greece, had an embolic event affecting his right-hand index finger, which was also complicated by severe atherosclerosis. His medical history revealed previous amputation due to diabetic complications, with signs of gangrene and necrosis present. The initial symptoms included a gangrenous index finger with necrotic tissue, significant discoloration, and compromised blood flow, accompanied by localized inflammation. Prior to treatment, the patient's condition required re-amputation..

[Audio] LYTONIC Plus 500mg Capsules are administered daily to target systemic inflammation, improve microvascular circulation, and reduce oxidative stress associated with the embolic and atherosclerotic pathology. Additionally, LYTONIC Gel is applied topically twice daily to the affected area to enhance localized blood flow, facilitate tissue oxygenation, and stimulate the wound healing process. Furthermore, supportive care includes regular wound cleaning and debridement to remove necrotic tissue, anticoagulant therapy to address the embolic event and prevent further clot formation, as well as management of underlying atherosclerosis with lipid-lowering agents and lifestyle modification.

[Audio] After three weeks of using Lytonic Plus and Gel, significant improvements were observed. A notable reduction in necrotic tissue was seen, with granulation tissue forming at the edges of the gangrenous area, indicating healthier and more viable tissue. Clear signs of revascularization were also evident, as shown by improved skin coloration and warmth in the surrounding tissue. Furthermore, a marked decrease in swelling and erythema was noted, suggesting effective control of localized inflammation..

[Audio] After six weeks of using LYTONIC Plus and Gel, complete recovery was observed. The wound showed significant healing and healthy tissue restoration. Moreover, no further surgical intervention or re-amputation was required. This outcome demonstrates the effectiveness of LYTONIC Plus and Gel in promoting faster healing and reducing complications in diabetic foot ulcers and chronic wounds..

[Audio] A 67-year-old male patient had a history of chronic, non-healing pressure ulcers that persisted despite multiple previous treatments. He had undergone anal fistula surgery five years earlier, which led to persistent pressure ulcers with associated infection, secretion, and tissue necrosis..

[Audio] LYTONIC Plus 500mg Capsules are administered daily to target systemic inflammation, improve microvascular circulation, and reduce oxidative stress associated with the embolic and atherosclerotic pathology. Additionally, LYTONIC Gel is applied topically twice daily to the affected area to enhance localized blood flow, facilitate tissue oxygenation, and stimulate the wound healing process. Furthermore, supportive care includes regular wound cleaning and debridement to remove necrotic tissue, anticoagulant therapy to address the embolic event and prevent further clot formation, as well as management of underlying atherosclerosis with lipid-lowering agents and lifestyle modification..

[Audio] After one week of using LYTONIC Plus & Gel, noticeable decreases were observed in necrotic tissue, with granulation tissue forming at the edges of the affected areas, indicating the start of revascularization, as evident from the improved skin coloration and warmth in the surrounding tissues. Additionally, marked reductions were seen in inflammation and edema, suggesting effective control over localized inflammation..

[Audio] Fistula healing has marked improvement, with progressive tissue regeneration and reduced inflammation. The volume and consistency of exudate have decreased significantly, indicating effective infection control and enhanced wound stabilization. Furthermore, necrotic tissue resolution has been substantial, with visible granulation tissue formation and improved vascularization at the wound site..

[Audio] The patient, a 40-year-old female, underwent an abdominoplasty procedure six months prior, but a substantial part of the surgical wound remained unhealed. Despite proper wound care, including the removal of excess skin from the lower abdominal area, the wound showed signs of infection and necrosis over time. A comprehensive assessment and treatment plan are needed to address this chronic non-healing wound..

[Audio] LYTONIC Plus 500mg Capsules are administered daily to target systemic inflammation, improve microvascular circulation, and reduce oxidative stress associated with the embolic and atherosclerotic pathology. LYTONIC Gel is applied topically twice daily to the affected area to enhance localized blood flow, facilitate tissue oxygenation, and stimulate the wound healing process. Supportive care includes regular wound cleaning and debridement to remove necrotic tissue, anticoagulant therapy to address the embolic event and prevent further clot formation, and management of underlying atherosclerosis with lipid-lowering agents and lifestyle modification..

[Audio] After one week of using LYTONIC Plus and Gel, significant reductions in inflammation are observed. Granulation tissue starts to form, and the wound edges begin to contract. The daily care routine with LYTONIC Gel promotes tissue regeneration. The wound is almost fully healed, with minimal scarring and complete epithelialization. LYTONIC therapy contributes to faster healing times and better tissue quality. Tissue viability improves significantly, with less necrotic tissue and clear signs of revascularization. There is a marked decrease in swelling and erythema, indicating effective control over localized inflammation..

[Audio] The complete regeneration of tissue layers within 15 days has led to the successful closure of the ulcer, marking a significant milestone in wound healing. This achievement is particularly notable given the complexity of this case. Furthermore, the regeneration of tissue layers enabled the surgeon to close the area without encountering necrotic tissue, highlighting the effectiveness of the treatment in promoting rapid wound healing and preventing complications such as necrosis..

[Audio] The patient information reveals that a 57-year-old individual from Qatar has experienced ulcers on their left little toe, along with swelling of the entire foot and inflammation in the groin, which have not healed due to diabetes and an embolic event combined with severe atherosclerosis. This patient has had ongoing treatment for this condition over the past 15 years, presenting with initial symptoms such as severe ulceration and discoloration of the right toe, accompanied by observable signs like necrosis, edema, and erythema. The patient also exhibits evidence of infection and possible ischemia. Further examination shows a swollen, discolored, and potentially infected area..

[Audio] LYTONIC Plus 500mg Capsules are administered daily to target systemic inflammation, improve microvascular circulation, and reduce oxidative stress associated with the embolic and atherosclerotic pathology. LYTONIC Gel is applied topically twice daily to the affected area to enhance localized blood flow, facilitate tissue oxygenation, and stimulate the wound healing process. Additionally, supportive care involves regular wound cleaning and debridement to remove necrotic tissue, anticoagulant therapy to address the embolic event and prevent further clot formation, and management of underlying atherosclerosis with lipid-lowering agents and lifestyle modification..

[Audio] Improved tissue viability is evident as a significant reduction in necrotic tissue is observed, with granulation tissue forming at the edges of the gangrenous area. Additionally, clear signs of revascularization are seen, characterized by improved skin coloration and warmth in the surrounding tissue. Furthermore, a marked decrease in swelling and erythema indicates effective control of localized inflammation..

[Audio] After one week, we observed significant improvements in the patient's condition. A noticeable reduction in pain levels was evident, allowing for better functionality and increased comfort. Our observations also suggest that the treatment has had a positive impact on overall circulation, likely resulting from the combined effects of LYTONIC Capsules and Gel in promoting vascular health. Furthermore, we have seen stabilization of symptoms related to atherosclerosis, which reduces the risk of further complications..

[Audio] The wound has shown significant healing and healthy tissue restoration, with improved tissue regeneration, reduced inflammation, and visible wound closure. With continued treatment, we have seen further improvement in wound healing, accompanied by minimized inflammation and scar formation. Ultimately, the wound has been completely healed, with minimal scarring and restored tissue integrity. We have also observed a reduction in inflammation and discoloration, as well as a visible improvement in wound size and appearance. Compared to conventional treatment, this outcome demonstrates the effectiveness of LYTONIC Plus 500mg Capsules and LYTONIC Gel in promoting faster healing and reducing complications in diabetic foot ulcers and chronic wounds..

[Audio] The patient, a 46-year-old male, was admitted to the hospital with a severe diabetic foot ulcer, accompanied by significant edema in the affected limb. This is likely a complication of long-standing uncontrolled diabetes. The patient also had chronic renal failure, which required him to undergo regular dialysis sessions to manage his condition..

[Audio] LYTONIC Plus 500mg Capsules are administered daily to target systemic inflammation, improve microvascular circulation, and reduce oxidative stress associated with the embolic and atherosclerotic pathology. LYTONIC Gel is applied topically twice daily to the affected area to enhance localized blood flow, facilitate tissue oxygenation, and stimulate the wound healing process. In addition, supportive care includes regular wound cleaning and debridement to remove necrotic tissue, anticoagulant therapy to address the embolic event and prevent further clot formation, and management of underlying atherosclerosis with lipid-lowering agents and lifestyle modification.

[Audio] The initial observations after one week show noticeable improvements in the patient's condition. The reduction in edema indicates better circulation and anti-inflammatory effects. The ulcer healing progress suggests accelerated wound healing, while the pain alleviation shows a significant reduction in reported pain levels. Additionally, the improved skin condition is characterized by enhanced texture and reduced erythema surrounding the ulcer. These results were observed after the first week of treatment using LYTONIC Plus 500mg Capsules and LYTONIC Gel 40ml..

[Audio] As we continue to observe the patient's progress, we notice the beginning signs of lymphatic activity around the affected areas, this indicates that the body is starting to naturally drain excess fluids and promote healing. Additionally, we see initial signs of revascularization in the little toe of the foot, which suggests that blood flow is improving. Furthermore, there is a continued decrease in swelling, resulting in noticeable improvement in the little toe. These findings demonstrate the effectiveness of LYTONIC Plus 500mg Capsules and LYTONIC Gel in promoting faster healing and reducing complications in diabetic foot ulcers and intractable chronic wounds..

[Audio] The remarkable efficacy of LYTONIC PLUS 500 mg and LYTONIC GEL has been demonstrated, preventing re-amputation and enhancing patient quality of life. This innovative treatment strategy provides a comprehensive solution for managing inflammation and oxidative damage, key contributors to chronic wound pathology. With its ability to significantly outperform individual treatments, this dual-therapy approach offers a promising advancement in the care of diabetic foot ulcers..